Patients looking to connect with MTA-verified cancer care providers in Italy can submit a free inquiry at Better by MTA — the Medical Tourism Association’s patient platform.
Why International Patients Choose Italy for Cancer Treatment
Italy is not the first country most international patients think of for medical tourism — and that is precisely what makes it a significant opportunity for patients who do their research. Italy’s public health system consistently ranks among the best in the world by the World Health Organization, and its leading private research hospitals operate at a clinical standard that matches or exceeds the most recognized cancer centers in the United States and northern Europe.
For international patients, Italy’s appeal lies in a specific combination: access to genuinely research-grade oncology — not just clinical treatment but active cancer research programs — in a European destination with excellent flight connectivity, English-language clinical teams, and costs that are meaningfully lower than equivalent care in the United States or United Kingdom.
Humanitas Research Hospital in Milan is the clearest example of what Italy offers in cancer care — a hospital that simultaneously functions as a clinical facility treating thousands of cancer patients per year and as an active research institution producing internationally published oncology research. For patients who want their treatment delivered by clinicians who are also advancing the science of their disease, Humanitas represents an option that is difficult to replicate elsewhere.
What Cancer Treatments Are Available at Humanitas?
Humanitas Research Hospital offers comprehensive oncology services across the full cancer care pathway, from diagnosis and staging through treatment, surgery, radiation, and long-term follow-up.
Medical Oncology and Precision Medicine
Humanitas’ oncology program is centered on a precision medicine approach — molecular profiling of each patient’s tumor to identify specific genetic mutations and biomarkers that guide targeted therapy selection. This approach means that rather than receiving a standard chemotherapy protocol, patients at Humanitas receive a treatment plan based on the specific molecular characteristics of their cancer.
Next-generation sequencing, liquid biopsy, and comprehensive biomarker panels are available to characterize tumor biology before treatment begins. The results directly influence which targeted therapy or immunotherapy agent is prescribed.
Radiation Oncology
Humanitas operates one of Italy’s most advanced radiation oncology programs, including IMRT (Intensity-Modulated Radiation Therapy), IGRT (Image-Guided Radiation Therapy), VMAT (Volumetric Modulated Arc Therapy), and stereotactic body radiation therapy (SBRT). These precision technologies allow high-dose radiation to be delivered to tumor targets while minimizing exposure to surrounding healthy tissue.
Surgical Oncology
Surgical oncology at Humanitas covers the full range of cancer-related surgical procedures, with a strong emphasis on minimally invasive techniques — laparoscopic and robotic-assisted surgery across colorectal, gastric, gynecological, urological, and thoracic oncology. The hospital’s surgical teams include subspecialty-trained oncologic surgeons whose focus is exclusively on cancer surgery within their specific anatomical domain.
Immunotherapy and Targeted Therapy
Checkpoint inhibitors, CAR-T cell therapy referral pathways, and a full range of targeted therapy agents are available based on molecular profiling results. Humanitas participates in international clinical trials, meaning some patients may have access to investigational treatments not yet widely available.
Hematology and Blood Cancer
Humanitas has a dedicated hematology program covering lymphomas, leukemias, multiple myeloma, and other blood cancers. Bone marrow transplantation (autologous and allogeneic) is performed within the hematology department.
Multidisciplinary Tumor Board
All complex oncology cases at Humanitas are reviewed by a multidisciplinary tumor board — a collaborative meeting of medical oncologists, surgeons, radiation oncologists, pathologists, and radiologists who jointly develop the treatment plan. International patients can request a remote tumor board review of their case before committing to travel.
Second Opinion Program
Humanitas offers a structured international second opinion program. Patients submit their pathology reports, imaging, and clinical history. A multidisciplinary team reviews the case and provides a formal written opinion with their recommended treatment approach. This service is available remotely and is one of the most sought-after services by international patients who have received a diagnosis at home and want expert European review before beginning treatment.
How Much Does Cancer Treatment Cost in Italy?
Treatment at Humanitas Research Hospital is priced at private hospital rates in Italy, which are significantly lower than equivalent care in the United States and modestly lower than comparable institutions in the United Kingdom and northern Europe.
Second opinion consultation (remote, written report):
Italy: $800–$2,500
US comparison: $2,000–$6,000
Chemotherapy (per cycle, excluding targeted agents):
Italy: $2,000–$5,000 per cycle
US comparison: $6,000–$15,000 per cycle
Targeted therapy / immunotherapy (per month):
Italy: $3,000–$10,000 per month depending on agent
US comparison: $10,000–$35,000 per month
Radiation therapy (full course):
Italy: $10,000–$22,000
US comparison: $35,000–$70,000
Surgical oncology (major cancer surgery):
Italy: $12,000–$30,000
US comparison: $50,000–$120,000+
Cost estimates are based on industry averages at Italian private hospitals for international patients. Exact costs depend on cancer type, stage, specific protocol, drug formulary, and individual treatment plan. Always request a fully itemized treatment quote. Request a personalized estimate through Better by MTA’s free inquiry system.
MTA Verified Cancer Hospital in Italy
Humanitas Research Hospital — MTA Verified
📍 Rozzano (Milan), Italy
Humanitas Research Hospital is a clinical and research institution located in Rozzano, on the southern outskirts of Milan, with exceptional transport connections to Milan’s two international airports (Malpensa and Linate). The hospital was founded in 1996 and has grown into one of Italy’s most productive clinical research environments — publishing extensively in international oncology journals and maintaining active research programs across multiple cancer types.
What distinguishes Humanitas from a purely clinical hospital is the integration of research into clinical practice. Humanitas University is co-located with the hospital, meaning that the same physicians treating cancer patients are also conducting and publishing research on those diseases. This research-clinical integration influences how individual patient cases are approached — with a level of molecular and scientific rigor that reflects an institution that is advancing its field, not just applying established protocols.
The hospital is internationally accredited and receives patients from across Europe, the Middle East, North America, and beyond through its dedicated international patient services program, which includes English-speaking coordinators, translation services, and remote consultation pathways.
Location: Via Alessandro Manzoni 56, 20089 Rozzano (Milan), Italy
Type: Private clinical and research hospital — Humanitas University co-located
Founded: 1996
Research Output: Internationally published oncology research across multiple cancer types
Languages: English, Italian, Arabic, and additional languages via translation services
International Services: Dedicated international patient coordinator, remote consultation program, second opinion service, visa support, accommodation guidance
Approach: Precision medicine — molecular profiling of tumor biology drives treatment selection
Technology: Next-generation sequencing, liquid biopsy, IMRT, IGRT, VMAT, SBRT, robotic surgical oncology
Cancer Specialties: Breast cancer, colorectal cancer, lung cancer, gastric and esophageal cancer, hepatobiliary cancer, gynecological oncology, urological oncology, lymphoma and leukemia, multiple myeloma, head and neck cancer, sarcoma, and neuroendocrine tumors.
Best for: International patients from Europe, the Middle East, and North America who want research-grade oncology delivered in a European academic hospital environment. Humanitas is particularly well suited for patients with complex or rare cancers who want molecular profiling and tumor board review before finalizing their treatment plan, patients seeking a European second opinion to complement or challenge a diagnosis received elsewhere, and patients who prefer a European destination for extended treatment stays.
→ View Humanitas Research Hospital on Better by MTA
Planning Your Cancer Treatment Trip to Italy
Start With a Remote Consultation
Humanitas’ international patient team and second opinion program allow patients to submit their complete medical records — pathology, imaging, surgical reports, and current treatment history — for remote review before traveling. For most international patients, this remote consultation is the right first step. It clarifies whether Humanitas can add value over what the patient is already receiving, what a treatment plan would look like, and what the logistics and cost of treatment would realistically involve.
How Long Will You Need to Stay?
Duration depends on treatment type. Patients seeking a second opinion and consultation only may need 2–5 days in Milan. Patients undergoing surgery typically stay 10–21 days. Patients beginning chemotherapy or radiation protocols may require stays of several weeks with periodic return visits over months. Humanitas’ international coordination team builds patient-specific logistics plans before travel is confirmed.
Getting to Milan
Milan is one of Europe’s most connected cities for international travel. Malpensa International Airport serves direct long-haul flights from North America, the Middle East, and Asia. Linate Airport serves European connections. The hospital in Rozzano is approximately 30 minutes from Malpensa by car and 20 minutes from Milan’s city center.
Accommodation in Milan
Milan’s accommodation options range from budget hotels to luxury properties, with a range of extended-stay apartments available near the hospital for patients undergoing multi-week treatment protocols. Humanitas’ international patient services team provides accommodation recommendations as part of the onboarding process.
Insurance and Payment
Humanitas works with international insurance providers for covered patients. For self-paying international patients, treatment is invoiced and processed through Better by MTA’s Mastercard-backed payment infrastructure, with 45+ payment methods accepted and cross-border payment handled cleanly without the wire complexity that international medical payments typically involve.
How to Choose a Cancer Hospital in Europe
✓ Ask about the hospital’s research activity. A hospital that publishes oncology research is not simply applying yesterday’s protocols — it is applying what it knows today. Ask what research the hospital conducts in your specific cancer type and whether you would be treated by clinicians who are actively researching it.
✓ Request molecular profiling as part of the treatment plan. Standard chemotherapy protocols without molecular profiling leave significant precision medicine value on the table. Ask any hospital you are considering whether tumor molecular profiling is a standard part of their treatment planning process.
✓ Ask for the tumor board composition. Who attends the tumor board review for your case? Medical oncologist, surgeon, radiation oncologist, pathologist, radiologist? The breadth of the board reflects the depth of collaborative review your case receives.
✓ Request a remote second opinion before traveling. Humanitas’ second opinion program allows patients to receive a formal written opinion from the multidisciplinary team without traveling to Italy first. This is the right first step for any patient seriously considering treatment in Milan.
✓ Confirm continuity of care arrangements. Ask how Humanitas coordinates with your oncologist at home. Will they provide complete, transferable medical records? Are they willing to participate in a case conference with your home team?
✓ Use an MTA Verified provider. Humanitas Research Hospital has been reviewed by the Medical Tourism Association for clinical standards, physician credentials, research credentials, and international patient services. Connect with Humanitas through Better by MTA.
Ready to Explore Cancer Treatment in Italy?
Better by MTA connects you directly with Humanitas Research Hospital’s international patient team. Submit a free inquiry — including your diagnosis, reports, and questions — and receive a personalized response with treatment options, cost estimates, and next steps.
→ Get My Free Cancer Treatment Quote
→ View Humanitas Research Hospital on Better by MTA
.png)
